Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then
Generix Biotech specializes in developing and manufacturing complex generic injectable products for oncology, endocrinology, hypertension, and cardiovascular treatments. Our expert team leverages cutting-edge technology to tackle challenging formulations, improving patient outcomes by providing vital medications.
Strategic Focus
We employ and highly focused approach, PS concentrating our resources on a select portfolio of generic medications.
Favorable Regulatory Landscape
Regulatory agencies across Mexico, Central America, and South America are prioritizing the review of generic comm drug applications, particulary for complex generics with FD limited market competiton. This shift, characterized by increased transparency and imporved efficiency, is creating a regulatory environment more conducive to the development and approval on innovative generic pharmaceuticals.
Strategic Growth Plan
Generix Biotech is committed to expanding its market presence across Mexico, Central and South America by continuing to develop strategic partnerships to commercialize our internally developed products
Products
Generix Biotech solves the complex generic gap
Complex generics demand unwavering focus and dedication to overcome significant supply, manufacturing, and analytical challenges. While mid-to- large cap pharmaceutical companies often lack the resource allocation flexibility for these inticate projects, Generix Biotch has positioned ourselves to fill this crucial market gap.
SELECT
Intelligent selection of high value generic Injectable opportunities
FOCUS
Focus on challenging generic Injectable products, with low or no competition
EXECUTE
We carefully select our in country partners ensuring our long term goals align completly.
PARTNER
Work in conjunction with our partners in each country bringing vital medications to market and improving patient access to high quality, affordable treatments.
We pinpoint high-value generic injectable prospects others miss
Step 1
Product identification through economic and technical due diligence
Step 2
Small batch manufacture and analytical testing
Step 3
Early stage R&D to support bioequivalence
Step 4
CGMP registration batches, stability studies, human BE study
Step 5
Regulatory submission and
approval
News & Article
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis.
